| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Institute of Pathology [I-M. S., T. G. P., R. B. P., T. P. P.], Department of Molecular Biology and Microbiology [D. R. R., H-J. K.], and Department of Genetics [S. S.], Case Western Reserve University, Cleveland, Ohio 44106
Malignant neoplasms, including colon cancers, are thought to arise from a single initiated progenitor cell. Aberrant crypt foci (ACF) are putative precursors of at least some colon cancers. The pattern of X chromosomal inactivation, which is identified by the differential methylation of a site near a polymorphic CAG repeat in the androgen receptor gene, was used to determine the clonality status of 11 ACF from eight female patients. Ten of 11 ACF were found to be monoclonal aberrations. The eleventh ACF appeared monoclonal, but nonrandom inactivation of the X chromosome was also seen in normal crypts from this patient. These results clearly demonstrate that: (a) a high percentage of ACF lesions are neoplastic rather than hyperplastic; and (b) ACF are the earliest identified neoplastic lesions in the colon.
This article has been cited by other articles:
![]() |
R. G. Stevens, T. P. Pretlow, D. P. Hurlstone, C. Giardina, and D. W. Rosenberg Comment re: "Sporadic Aberrant Crypt Foci Are Not a Surrogate Endpoint for Colorectal Adenoma Prevention" and "Aberrant Crypt Foci in the Adenoma Prevention with Celecoxib Trial" Cancer Prevention Research, August 1, 2008; 1(3): 215 - 216. [Full Text] [PDF] |
||||
![]() |
O. K. Glebov, L. M. Rodriguez, P. Soballe, J. DeNobile, J. Cliatt, K. Nakahara, and I. R. Kirsch Gene Expression Patterns Distinguish Colonoscopically Isolated Human Aberrant Crypt Foci from Normal Colonic Mucosa. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2253 - 2262. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cohen, R. Mustafi, A. Chumsangsri, N. Little, J. Nathanson, S. Cerda, S. Jagadeeswaran, U. Dougherty, L. Joseph, J. Hart, et al. Epidermal Growth Factor Receptor Signaling Is Up-regulated in Human Colonic Aberrant Crypt Foci Cancer Res., June 1, 2006; 66(11): 5656 - 5664. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Luo, G.-Q. Shen, K. A. Stiffler, Q. K. Wang, T. G. Pretlow, and T. P. Pretlow Loss of heterozygosity in human aberrant crypt foci (ACF), a putative precursor of colon cancer Carcinogenesis, June 1, 2006; 27(6): 1153 - 1159. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Volate, D. M. Davenport, S. J. Muga, and M. J. Wargovich Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin) Carcinogenesis, August 1, 2005; 26(8): 1450 - 1456. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hulit, C. Wang, Z. Li, C. Albanese, M. Rao, D. Di Vizio, S. Shah, S. W. Byers, R. Mahmood, L. H. Augenlicht, et al. Cyclin D1 Genetic Heterozygosity Regulates Colonic Epithelial Cell Differentiation and Tumor Number in ApcMin Mice Mol. Cell. Biol., September 1, 2004; 24(17): 7598 - 7611. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Brittan and N A Wright STEM CELL IN GASTROINTESTINAL STRUCTURE AND NEOPLASTIC DEVELOPMENT Gut, June 1, 2004; 53(6): 899 - 910. [Full Text] [PDF] |
||||
![]() |
L.-C. Chen, C.-Y. Hao, Y. S. Y. Chiu, P. Wong, J. S. Melnick, M. Brotman, J. Moretto, F. Mendes, A. P. Smith, J. L. Bennington, et al. Alteration of Gene Expression in Normal-Appearing Colon Mucosa of APCmin Mice and Human Cancer Patients Cancer Res., May 15, 2004; 64(10): 3694 - 3700. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. Pretlow, W. Edelmann, R. Kucherlapati, T. G. Pretlow, and L. H. Augenlicht Spontaneous Aberrant Crypt Foci in Apc1638N Mice with a Mutant Apc Allele Am. J. Pathol., November 1, 2003; 163(5): 1757 - 1763. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Luo, B. Li, and T. P. Pretlow DNA Alterations in Human Aberrant Crypt Foci and Colon Cancers by Random Primed Polymerase Chain Reaction Cancer Res., October 1, 2003; 63(19): 6166 - 6169. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Li, L. Myeroff, D. Smiraglia, M. F. Romero, T. P. Pretlow, L. Kasturi, J. Lutterbaugh, R. M. Rerko, G. Casey, J.-P. Issa, et al. SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers PNAS, July 8, 2003; 100(14): 8412 - 8417. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Preston, W.-M. Wong, A. O.-O. Chan, R. Poulsom, R. Jeffery, R. A. Goodlad, N. Mandir, G. Elia, M. Novelli, W. F. Bodmer, et al. Bottom-up Histogenesis of Colorectal Adenomas: Origin in the Monocryptal Adenoma and Initial Expansion by Crypt Fission Cancer Res., July 1, 2003; 63(13): 3819 - 3825. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Wali, S. Khare, M. Tretiakova, G. Cohen, L. Nguyen, J. Hart, J. Wang, M. Wen, A. Ramaswamy, L. Joseph, et al. Ursodeoxycholic Acid and F6-D3 Inhibit Aberrant Crypt Proliferation in the Rat Azoxymethane Model of Colon Cancer: Roles of Cyclin D1 and E-Cadherin Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1653 - 1662. [Abstract] [Full Text] [PDF] |
||||
![]() |
N A Wright and R Poulsom Top down or bottom up? Competing management structures in the morphogenesis of colorectal neoplasms Gut, September 1, 2002; 51(3): 306 - 308. [Full Text] |
||||
![]() |
R G Hardy, C Tselepis, J Hoyland, Y Wallis, T P Pretlow, I Talbot, D S A Sanders, G Matthews, D Morton, and J A Z Jankowski Aberrant P-cadherin expression is an early event in hyperplastic and dysplastic transformation in the colon Gut, April 1, 2002; 50(4): 513 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Velcich, W. Yang, J. Heyer, A. Fragale, C. Nicholas, S. Viani, R. Kucherlapati, M. Lipkin, K. Yang, and L. Augenlicht Colorectal Cancer in Mice Genetically Deficient in the Mucin Muc2 Science, March 1, 2002; 295(5560): 1726 - 1729. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hartmann, G. Schlake, D. Zaak, E. Hungerhuber, A. Hofstetter, F. Hofstaedter, and R. Knuechel Occurrence of Chromosome 9 and p53 Alterations in Multifocal Dysplasia and Carcinoma in Situ of Human Urinary Bladder Cancer Res., February 1, 2002; 62(3): 809 - 818. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. P. Hao, T. G. Pretlow, J. S. Rao, and T. P. Pretlow {beta}-Catenin Expression Is Altered in Human Colonic Aberrant Crypt Foci Cancer Res., November 1, 2001; 61(22): 8085 - 8088. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. Pretlow, R. P. Bird, Y. Yamada, Y. Hirose, A. Hara, and H. Mori Correspondence re: Y. Yamada et al., Frequent {beta}-Catenin Gene Mutations and Accumulations of the Protein in the Putative Preneoplastic Lesions Lacking Macroscopic Aberrant Crypt Foci Appearance, In Rat Colon Carcinogenesis. Cancer Res., 60: 3323-3327, 2000; and Sequential Analysis of Morphological and Biological Properties of {beta}-Catenin-accumulated Crypts, Provable Premalignant Lesions Independent of Aberrant Crypt Foci in Rat Colon Carcinogenesis. Cancer Res., 61: 1874-1878, 2001. Cancer Res., October 1, 2001; 61(20): 7699 - 7701. [Full Text] [PDF] |
||||
![]() |
M. Pedroni, E. Sala, A. Scarselli, F. Borghi, M. Menigatti, P. Benatti, A. Percesepe, G. Rossi, M. Foroni, L. Losi, et al. Microsatellite Instability and Mismatch-Repair Protein Expression in Hereditary and Sporadic Colorectal Carcinogenesis Cancer Res., February 1, 2001; 61(3): 896 - 899. [Abstract] [Full Text] |
||||
![]() |
X. P. Hao, T. G. Pretlow, J. S. Rao, and T. P. Pretlow Inducible Nitric Oxide Synthase (iNOS) Is Expressed Similarly in Multiple Aberrant Crypt Foci and Colorectal Tumors from the Same Patients Cancer Res., January 1, 2001; 61(2): 419 - 422. [Abstract] [Full Text] |
||||
![]() |
M. J. Wargovich, A. Jimenez, K. McKee, V. E. Steele, M. Velasco, J. Woods, R. Price, K. Gray, and G. J. Kelloff Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression Carcinogenesis, June 1, 2000; 21(6): 1149 - 1155. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Jang and L. Mao Methylation Patterns in Human Androgen Receptor Gene and Clonality Analysis Cancer Res., February 1, 2000; 60(4): 864 - 866. [Abstract] [Full Text] |
||||
![]() |
X. P. Hao, J. E. Willis, T. G. Pretlow, J. S. Rao, G. T. MacLennan, I. C. Talbot, and T. P. Pretlow Loss of Fragile Histidine Triad Expression in Colorectal Carcinomas and Premalignant Lesions Cancer Res., January 1, 2000; 60(1): 18 - 21. [Abstract] [Full Text] |
||||
![]() |
C. M. Fenoglio-Preiser and A. Noffsinger Review Article: Aberrant Crypt Foci: A Review Toxicol Pathol, November 1, 1999; 27(6): 632 - 642. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |